Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 21, 2021; 27(23): 3182-3207
Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3182
Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3182
Category | Epigenetic effect | Effect on HBV | Ref. | |
Chromatin remodeling enzymes | ||||
Histone acetyltransferase p300/CBP | Writer | Increases H3K122a | Activation | Ananthanarayanan et al[99] and Tropberger et al[221] |
P300/CBP-associated factor (PCAF) | Writer | Activation | Levrero et al[82] and Rivière et al[93] | |
Histone deacetylase 1 (HDAC1) | Eraser | Reduces acetylation of H3K9 and H3K27 with IFN | Inhibition | Pollicino et al[57] and Liu et al[98] |
Sirtuin 1 and 3 (SIRT1/3) | Eraser | Reduces H3K9me3 | Inhibition | Belloni et al[105] and Ren et al[114] |
Enhancer of zeste homolog 2 (EZH2) | Writer | Increases H3K27ac and H3K27me3 | Inhibition | Zhang et al[89] |
Histone acetyltransferase 1 (HAT1) | Writer | Overexpression of HAT1 promotes acetylation of H3K27, H4K5 and H4K12 | Activation | Yang et al[195] |
Mixed lineage leukemia protein 3 (MLL3) | Writer | Increases H3K4me3 | Activation | Tropberger et al[86] and Ananthanarayanan et al[99] |
Protein arginine methyltransferase (PRMT) | Writer | PRMT5 interacts with HBc to increase H4R3me2s | Inhibition | Zhang et al[89] |
Demethylases (KDMs) | Eraser | Increases H3K79me and function to transcriptional repression via SIRT1-mediated chromatin silencing | Inhibition | Kang et al[222] |
Histone methyltransferase suppressor of variegation 3-9 homolog 1 (SUV39H1) | Writer | Increases H3K9me3 | Inhibition | Peng and Karpen[223,224] |
DNA methyltransferase (DNMTs) | Writer | Inhibition | Vivekanandan et al[81] | |
Methyl-CpG binding protein (MBPs) | Reader | Recruit chromatin remodeling and histone-modifying complexes to methylated sites resulting in histone methylation | Inhibition | Lopez-Serra and Esteller[94] |
Cellular transcription factors | ||||
Activating transcription factor 2 (ATF 2) | Inhibition viral transcription | Inhibition | Choi et al[225] | |
cAMP response element binding protein (CREB) | Enhances transcription | Activation | Kim et al[226] and Song et al[227] | |
Nuclear factor 1 (NF1) | Reader | Activation | Ori et al[228] and Shaul et al[229] | |
Transcription factor Yin Yang 1 (YY1) | Inhibition | Belloni et al[199] and Nakanishi-Matsui et al[230] | ||
Specificity protein 1 (SP1) | Reader | Activation | Raney and McLachlan[231], Raney et al[232] and Li and Ou[233] | |
Nuclear Transcription Factor Y (NF-Y) | Recruit enzymes that both methylate and acetylate histone proteins | Activation | Lu and Yen[234], Maity and de Crombrugghe[235] and Nardini et al[236] | |
Activator protein 1(AP-1) | Activation | Ren et al[111] and Choi et al[237] | ||
TATA binding protein (TBP) | Reader | Activation | Bogomolski-Yahalom et al[238] and Chen et al[239] | |
Prospero-related homeobox protein (Prox1) | Inhibition | Qin et al[240] | ||
Nuclear factor kappa-B (NF-κB) | Inhibition | Lin et al[241] | ||
Histone-lysine N-methyltransferase SETDB1 | Writer | In the absence of HBx, SETDB1 increases H3K9me2 and H3K9me3 | Inhibition | Rivière et al[93] |
Hepatocyte factors | ||||
Retinoid X receptors (RXRα) | Increases acetylation of histones H4 and H3 by recruiting p300 to cccDNA minichromosome | Activation | Zhang et al[89] and Nkongolo et al[242] | |
Small heterodimer partner (SHP) | Inhibition | Oropeza et al[243] | ||
CAAT enhancer-binding protein α and ζ (C/EBP) | C/EBP in low concentrations; C/EBP in high concentrations | Activation; Inhibition | Raney and McLachlan[231] and | |
Hepatocyte nuclear factor 1 α and β (HNF1) | HNF1 and Oct 1 are essential co-activators of transcription. High HNF1 levels increase NF-κB expression and resulting in transcription inhibition | Activation and inhibition | Zhou and Yen[245], Zheng et al[246] and Lin et al[247] | |
Hepatocyte nuclear factor 3 α, β, and γ (HNF3) | Functions as a chromatin remodeler | Activation | Chen et al[248] and Li et al[249] | |
Hepatocyte nuclear factor 4 (HNF4) | Activation | Zheng et al[246], Cho et al[250] and Long et al[251] | ||
Testicular orphan receptor 4 (TR4) | Inhibition | Lin et al[252] | ||
Type I interferon (IFN-α) | Reduced acetylation of H3K9and H3K27 | Inhibition | Pollicino et al[57], Liu et al[98] and Yuan et al[253] |
- Citation: Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207
- URL: https://www.wjgnet.com/1007-9327/full/v27/i23/3182.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i23.3182